Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Dexamethasone
Drug ID BADD_D00623
Description Dexamethasone, or MK-125, is a corticosteroid fluorinated at position 9 used to treat endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions.[L10701] Developed in 1957, it is structurally similar to other corticosteroids like [hydrocortisone] and [prednisolone].[A188724] Dexamethasone was granted FDA approval on 30 October 1958.[L10695] In a press release for the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial on 16 June 2020, dexamethasone was recommended for use in COVID-19 patients with severe respiratory symptoms. Dexamethasone reduced deaths by approximately one third in patients requiring ventilation and by one fifth in those requiring oxygen.[L14318]
Indications and Usage
Intranasal aerosol: for the treatment of allergic ot inflammatory nasal conditions, and nasal polyps
Marketing Status Prescription; Discontinued
ATC Code A01AC02; C05AA09; D07AB19; D07XB05; D10AA03; H02AB02; R01AD03; S01BA01; S01CB01; S02BA06; S03BA01
DrugBank ID DB01234
KEGG ID D00292
MeSH ID D003907
PubChem ID 5743
TTD Drug ID D0IT2G
NDC Product Code 42195-127; 42195-721; 55718-156; 0121-0907; 70518-1534; 69306-112; 15014-211; 68071-2321; 79572-012; 63187-383; 55154-4914; 55289-903; 45865-989; 57582-031; 68788-7142; 63629-4127; 43063-266; 68788-7267; 51552-0430; 63629-7850; 55718-157; 61919-269; 71879-001; 47781-914; 0054-4180; 0023-3348; 55700-961; 0054-8175; 55700-854; 72189-254; 71205-013; 60219-2043; 67296-1413; 60219-2044; 67296-0326; 0054-8180; 0054-8179; 51407-361; 47781-916; 42195-121; 48102-051; 63629-3742; 22552-0039; 70382-204; 68071-4127; 38779-0405; 55154-4901; 70518-3050; 42195-221; 55289-582; 71161-138; 42195-270; 42195-151; 0054-4184; 63629-4129; 54879-003; 60432-466; 0054-3177; 52128-170; 50090-0089; 50090-0091; 72893-015; 0054-4183; 0054-8176; 48102-050; 0054-4186; 64980-509; 0395-8142; 71205-012; 61919-827; 50090-0088; 50090-0090; 82298-111; 65089-0045; 70518-2998; 0054-4179; 46439-8765; 49999-059; 0054-4181; 48102-049; 51927-1081; 69306-111; 49452-2465; 0054-8174; 63629-7806; 0998-0615; 0009-5019; 42195-149; 0054-4182; 48102-052; 0121-1814; 55718-133; 0054-8181; 42195-490; 0054-8183; 48102-047; 69306-114; 79043-200; 60722-3013; 63187-561
Synonyms Dexamethasone | Methylfluorprednisolone | Hexadecadrol | Decameth | Decaspray | Dexasone | Dexpak | Maxidex | Millicorten | Oradexon | Decaject | Decaject-L.A. | Decaject L.A. | Hexadrol
Chemical Information
Molecular Formula C22H29FO5
CAS Registry Number 50-02-2
SMILES CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
Chemical Structure
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal distension07.01.04.001--
Abdominal pain07.01.05.002--
Abdominal pain lower07.01.05.010--Not Available
Abdominal pain upper07.01.05.003--
Abscess11.01.08.001--Not Available
Acanthosis nigricans16.32.01.003; 23.01.04.0010.000687%Not Available
Acne23.02.01.0010.005149%Not Available
Acute febrile neutrophilic dermatosis01.02.01.006; 23.03.03.0330.000687%Not Available
Acute hepatic failure09.01.03.001--Not Available
Acute lymphocytic leukaemia01.10.01.001; 16.01.01.0010.000269%Not Available
Acute myeloid leukaemia01.10.05.001; 16.01.05.0010.000358%Not Available
Acute myocardial infarction02.02.02.001; 24.04.04.001--Not Available
Acute psychosis19.03.01.0010.000687%Not Available
Acute pulmonary oedema02.05.02.004; 22.01.03.0050.000269%Not Available
Acute respiratory distress syndrome22.01.03.0010.000806%
Acute respiratory failure14.01.04.004; 22.02.06.0010.000358%Not Available
Adrenal insufficiency05.01.02.001; 14.11.01.0040.003776%
Adrenal suppression05.01.02.002; 14.11.01.0050.001030%Not Available
Adrenocortical insufficiency acute05.01.02.005; 14.11.01.0200.001716%Not Available
Affective disorder19.04.04.0010.001716%Not Available
Ageusia07.14.03.003; 17.02.07.001--Not Available
Aggression19.05.01.001--Not Available
Agitation17.02.05.012; 19.06.02.001--
Alanine aminotransferase increased13.03.01.003--
Alkalosis hypokalaemic14.01.02.002--Not Available
Alopecia23.02.02.001--
Altered state of consciousness17.02.04.001; 19.07.01.0030.002060%Not Available
Amenorrhoea05.05.01.002; 21.01.02.001--
Amnesia17.03.02.001; 19.20.01.001--
Anaemia01.03.02.0010.019224%
The 1th Page    1 2 3 4 5    Next   Last    Total 31 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene